Herbal and nonherbal supplements in medical-psychiatric patient populations

Psychiatric Clinics of North America

Volumn 25, Issue 1, 2002, Pages 211-230

  Crone, Catherine C ^a,b   Gabriel, Geoffrey ^c  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARNITINE; CHONDROITIN SULFATE; CHROMIUM PICOLINATE; CLOMIPRAMINE; CRATAEGUS EXTRACT; DIGOXIN; EPHEDRA EXTRACT; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLUCOSAMINE SULFATE; GLYCOSIDE; HEPARIN; HERBACEOUS AGENT; HUPERZINE A; HYPERICUM PERFORATUM EXTRACT; INSULIN; KAVA; LEVACECARNINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; PROTEINASE INHIBITOR; S ADENOSYLMETHIONINE; UNINDEXED DRUG; VALERIAN; VISCUM ALBUM EXTRACT; WARFARIN;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; ANXIETY NEUROSIS; ASTHMA; ATHEROSCLEROSIS; CANCER; CONGESTIVE HEART FAILURE; DEPRESSION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG INDICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; OSTEOARTHRITIS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SIDE EFFECT;

EID: 0036208265     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(03)00059-5     Document Type: Review

References (190)

1. Studies on hypogycemic effects of fruit pulp, seed, and whole plant of Momordica charantia on normal and diabetic model rats
2. Meta-analysis of the effects of soy protein intake on serum lipids
3. Beneficial effects of chromium for people with diabetes
4. Chromium, glucose intolerance, and diabetes
5. N-3 polyunsaturated fatty acids and the cardiovascular system
6. Effects of dietary supplementation with fish oil lipids on mild asthma
7. Evaluation of the ergogenic properties of ginseng
8. Huperzine A: A potential therapeutic agent for treatment of Alzheimer's disease
9. Neuropharmacology of S-adenosyl-L-methionine
10. Glucosamine
11. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine
12. Garlic preparations for prevention of atherosclerosis
13. Herbal interventions in asthma and allergy
14. Ademetionine (S-adenosylmethionine) neuropharmacology: Implications for drug therapies in psychiatric and neurological disorders
15. Improvement of immune functions in HIV infection by sulfur supplementation: Two randomized trials
16. S-adenosyl-L-methionine (SAMe) as antidepressant: Meta-analysis of clinical studies
17. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: A reanalysis of a double-blind, placebo-controlled study using the trilinear approach
18. Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer
19. Lifetime use of alternative therapy: A study of Florida residents
20. Garlic as a possible risk for postoperative bleeding
21. Fish oils and bipolar disorder. A promising but untested treatment
22. Clues to the mechanism of action of acetyl-L-carnitine in the central nervous system
23. Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion
24. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease
25. Switch and S-adenosylmethionine
26. Ginkgolide and bilobalide biosynthesis in Ginkgo biloba: I. Studies of synthesis, translocation and accumulation of ginkgolides and bilobalide
27. Effect of chromium picolinate on insulin sensitivity in vivo
28. Chromium picolinate toxicity
29. Tremor induced by s-adenosyl-L-methionine: Possible relation to L-dopa effects
30. Parkinson's disease-like effects of S-adenosyl-L-methionine: Effects of L-dopa
31. Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients
32. Soy protein in the management of hyperlipidemia
33. Medicinal plants and dietary supplements: Sources for innovative treatments or adjuncts?
34. In vitro receptor binding and enzyme inhibition by hypericum perforatum extract
35. Use of herbal medicines among consultation-liaison populations: A review of current information regarding risks, interactions, and efficacy
36. Complementary medicine: Implications toward medical treatment and the patient-physician relationship
37. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
38. Glucosamine sulfate for osteoarthritis
39. Kavapyrones and resin: Studies on GABA (A), and GABA (B) and benzodiazepine binding sites in rodent brain
40. Hypoglycemic effect of Momordica charantia extracts
41. Nutraceuticals as therapeutic agents in osteoarthritis - The role of glucosamine, chondroitin sulfate, and collagen hydrolystae
42. N-acetylcysteine replenishes glutathione in HIV infection
43. Asthma
44. The use of alternative health care by a family practice population
45. N-acetyl-cysteine in the therapy of HIV-positive patients
46. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients
47. Trends in alternative medicine use in the United States, 1990-1997
48. Use of alternative health care by family practice patients
49. Alternative and complementary medicine: A source of improved therapies for asthma? A challenge for redefining the specialty?
50. Soy protein and cardiovascular disease: A statement for healthcare professionals from the nutrition committee of the AHA
51. Harmless herbs? A review of the recent literature
52. Second thoughts about the safety of St. John's wort
53. Ginkgo biloba for dementia: A systematic review of double-blind placebo-controlled trials
54. Mistletoe for cancer?
55. Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant
56. Gingko biloba: A case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy
57. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10
58. Systemic contact dermatitis caused by oral chromium picolinate
59. Treatment of advanced pancreatic cancer with mistletoe: Results of a pilot trial
60. Dietary supplements and natural products as psychotherapeutic agents
61. Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: A prospective study
62. Cardiac complications and delirium associated with valerian root withdrawal
63. St. John's wort for depression: A systematic review
64. Panax ginseng pharmacology: A nitric oxide link?
65. Herbal-drug therapy interactions: A focus on dementia
66. Anxiety in the medically ill
67. SSRIs and St. John's wort: Possible toxicity?
68. Diets containing whey proteins or soy protein isolate protect aginst 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats
69. Glutathione deficiency is associated with impaired survival in HIV disease
70. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children
71. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure
72. The scientific basis for the reputed activity of valerian
73. Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993
74. Herbal medicines for asthma: A systematic review
75. Over-the-counter chromium picolinate
76. Toxic interaction of S-adenosylmethionine and clomipramine
77. S-adenosylmethionine in depression: A literature review and preliminary report
78. The role of chromium in nutrition and therapeutics and as a potential toxin
79. The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China
80. Green tea consumption and the risk of pancreatic and colorectal cancers
81. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)
82. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain
83. Unconventional therapies for cancer: 2. Green tea
84. Unconventional therapies for cancer: 3. Iscador
85. Prevalence of physical illness among psychiatric inpatients who die of natural causes
86. Human P450 metabolism of warfarin
87. Proof of efficacy of the Gingko biloba extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia
88. Increased oxidative stress in patients with congestive heart failure
89. Clinical applications of N-acetylcysteine
90. L-carnitine, therapeutic applications of a conditionally-essential amino acid
91. The effects of coenzyme Q10 in patients with congestive heart failure
92. Hypomania associated with omega-3 fatty acids
93. Ginkgo biloba for cerebral insufficiency
94. Mistletoe treatment for cancer: Review of controlled trials in humans
95. Omega-3 fatty acids in respiratory disease: A review
96. The effects of valerian, propranolol, and their combination on activation, performance, and mood of healthy volunteers under social stress conditions
97. Fats for brains
98. Huperzine A: A possible lead structure in the treatment of Alzheimer's disease
99. St. John's wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy
100. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United Sates
101. Prevention of cardiac sudden death by N-3 fatty acids: A review of the evidence
102. Improvement in glucose tolerance due to Momordica charantia (Karela)
103. A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia
104. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis
105. Unconventional therapies in asthma: An overview
106. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion
107. St. John's wort for depression: An overview and meta-analysis of randomized clinical trials
108. Actions of Gingko biloba related to potential utility for the treatment of conditions involving cerebral hypoxia
109. Hepatoxicity of herbal remedies
110. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics
111. Herbal medicine for the treatment of cardiovascular disease: Clinical considerations
112. Association of Ginkgo biloba with intracerebral hemorrhage
113. Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis
114. Assessment of depression and grief reactions in the medically ill
115. Effects of soy protein supplementation on epithelial proliferation in the histologically normal human breast
116. In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and barbiturate receptors in rat brain
117. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer
118. Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: A pilot study
119. Chromium homeostatis in patients with Type II (NIDDM) diabetes
120. Perspectives on therapy of cardiovascular disease with coenzyme Q10
121. St. John's wort: Three cases of possible mania induction
122. Effects of hypericum extract on the expression of serotonin receptors
123. Fish oil and cardiovascular disease: Lipids and arterial function
124. Potential metabolic interaction between St John's wort and theophylline
125. Mania associated with St. John's wort
126. Effect of ginseng radix on GLUT2 protein content in mouse liver in normal and epinephrine-induced hyperglycemic mice
127. Effects of dietary supplementation with n-3 fatty acids compared with n-6 fatty acids on bronchial asthma
128. Nutrients and HIV: Part three-N-acetylcysteine, alpha-lipoic acid, L-glutamine, and L-carnitine
129. Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy
130. Indinavir concentrations and St. John's wort
131. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
132. The treatment of human cancer with agents prepared from bovine cartilage
133. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium
134. Antidiabetic effects of subfractions from fenugreek seeds in diabetic dogs
135. A phase II study of Catrix-S in solid tumors
136. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report
137. Glucosamine sulfate use in osteoarthritis
138. Acute heart transplant rejection due to Saint John's wort
139. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease
140. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of dibetes
141. Kindling: Basic mechanisms and clinical validity
142. 4-Hydroxyisoleucine: A novel amino acid potentiator of insulin secretion
143. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients
144. Kava and dopamine antagonism
145. The effect of valerian extract on sleep polygraphy in poor sleepers: A pilot study
146. Effects of the disruption of transmethylation in the central nervous system: An animal model
147. Omega-3 fatty acids: The missing link?
148. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: A randomized, double-blind controlled trial
149. Effect of fenugreek seeds on blood glucose and serum lipids in Type I diabetes
150. Effectiveness of St John's wort in major depression
151. Kava: An overview
152. N-3 polyunsaturated fatty acids and cardiac mortality
153. Long-term acetyl-L-carnitine treatment in Alzheimer's disease
154. Reduced effect of warfarin caused by ubidecarenone
155. S-adenosylmethionine in psychiatric disorders. Historical perspective and current aspects
156. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial
157. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: A randomized controlled clinical trial
158. Garlic for treating hypercholesterolemia: A meta-analysis of randomized clinical trials
159. Mood stabilizers: Shared mechanisms of action at post-synaptic signal transduction and kindling processes
160. Omega-3 fatty acids and bipolar disorder: A review
161. Omega-3 fatty acids in bipolar disorder
162. Are omega-3 fatty acids beneficial in depression but not mania?
163. Pharmacologic aspects of S-adenosylmethionine: Pharmacokinetics and pharmacodynamics
164. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men
165. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease
166. A 1-year controlled trial of acetyl-L-carnitine in early-onset AD
167. Modulation of cytokine expression by hypericum extract
168. Green tea and the risk of gastric cancer in Japan
169. The efficacy of gingko for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial
170. Huperzine A: A potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate
171. Effect of dietary supplementation with polyunsaturated fatty acids on bronchial hyperreactivity in subjects with seasonal asthma
172. Relationship between glucose tolerance factor and low-molecular-weight chromium binding substance
173. Mechanisms of chromium action: Low-molecular-weight chromium binding substance
174. n-3 fatty acid and the prevention of coronary atherosclerosis
175. American ginseng (panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with Type 2 diabetes mellitus
176. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in Type 2 diabetes
177. Beyond benzodiazepines: Alternative pharmacologic agents for the treatment of insomnia
178. Anticholinesterase effects of huperzine A, E 2020, and tacrine in rats
179. Triglyceride-lowering effect of omega-3-LC-polyunsaturated fatty acids - A review
180. Cholinesterase inhibitors and Ginkgo extracts: Comparison of published placebo-controlled efficacy studies of a least six months' duration
181. Comparison of St. John's wort and imipramine for treating depression: Randomised controlled trial
182. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease
183. Huperzine-A in capsules and tablets for treating patients with Alzheimer disease
184. Acute generalized exanthematous pustulosis induced by chromium picolinate
185. Green tea consumption and risk of stomach cancer: A population-based case-control study in Shanghai, China
186. Modifications in brain cAMP- and calcium/calmodulin-dependent protein kinases induced by treatment with S-adenosylmethionine